We combine semaglutide with nutrition guidance and exercise protocols to protect lean mass
A new study published in The BMJ has found that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), may face a higher risk of developing non-scarring hair loss (alopecia) compared with patients taking other commonly prescribed diabetes medicines
High dose glutathione therapy, or IV glutathione, is a natural treatment for Parkinsons disease that can replenish the body and the brain with glutathione
FDA-approved medications that regulate appetite, blood sugar, and metabolism for significant sustained weight loss
Retatrutide owns the incretin and glucagon territory, driving both reduced intake and increased burn
Questions on this page cover handling, storage, documentation, and ordering